Posts Tagged ‘CMS’
No DIR Reform in CMS’ 2020 Final Drug Pricing Rule
Despite over 4,000 comments from pharmacists and organizations like Currus, NCPA, the National Association of Chain Drug Stores (NACDS), and others across the country encouraging change, CMS elected not to address DIR reform in their final 2020 drug pricing rule released on Thursday. CMS said in a statement that they “will continue to carefully review…
Read MoreThousands Sign on in Support of DIR Proposal
According to NCPA, nearly 3,500 pharmacists and over 150 pharmacy stakeholder organizations have supported a potential change in DIR fees in the Centers for Medicare and Medicaid Services’ (CMS) proposed pricing rule for 2020. The proposed change would eliminate retroactive DIR fees and issue them at the point of sale. This move would save patients…
Read MoreChanges to DIR Fees Featured in CMS’ Proposed Rule for 2020
On Monday, Nov. 26, 2018, the Centers for Medicare & Medicaid Services (CMS) released their proposed rule for 2020 titled Modernizing Part D and Medicare Advantage to Lower Drug Prices and Reduce Out-of-Pocket Expenses. The proposed rule supplements President Trump’s Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs that was released in May 2018…
Read More